Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream (4%, 6%, 8%)
Status:
Not yet recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This is a Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2
Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream 4%, 6%, and
8% BID for the Treatment of Signs and Symptoms of Dry Eye Disease.